Hammad Ur Rehman Bajwa

Dr. Hammad Ur Rehman Bajwa

Ankara University, Ankara, Turkey (Türkiye)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in Life
Verified
Journal Article
Open access
PDF file
Hammad Ur Rehman BajwaHammad Ur Rehman Bajwa
Hammad Ur Rehman Bajwa
MKMuhammad kasib Khan
Muhammad kasib Khan
ZAZaheer Abbas
Zaheer Abbas
RRRoshan Riaz
Roshan Riaz
Tauseef RehmanTauseef Rehman
Tauseef Rehman
Abdulaziz AlouffiAbdulaziz Alouffi
Abdulaziz Alouffi
Protozoa, helminths and ectoparasites are the major groups of parasites distributed worldwide. Currently, these parasites are treated with chemotherapeutic antiprotozoal drugs, anti-helminthic and anti-ectoparasitic agents, but, with the passage of time, resistance to these drugs has developed due to overuse. In this scenario, nanoparticles are proving to be a major breakthrough in the treatment and control of parasitic diseases. In the last decade, there has been enormous development in the field of nanomedicine for parasitic control. Gold and silver nanoparticles have shown promising results in the treatments of various types of parasitic infections. These nanoparticles are synthesized through the use of various conventional and molecular technologies and have shown great efficacy. They work in different ways, that include damaging the parasite membrane, DNA (Deoxyribonucleic acid) disruption, protein synthesis inhibition and free-radical formation. These agents are effective against intracellular parasites as well. Other nanoparticles, such as iron, nickel, zinc and platinum, have also shown good results in the treatment and control of parasitic infections. It is hoped that this research subject will become the future of modern drug development. This review summarizes the methods that are used to synthesize nanoparticles and their possible mechanisms of action against parasites.